India's largest hospital chain: 78 hospitals plus pharmacy, diagnostics and Apollo 24/7 digital care
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 70 | 72 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 3.3k | 4.5k | 5.6k | 6.1k | 6.9k | 8.1k | 9.0k | 9.4k |
| Borrowings | 3.6k | 4.2k | 4.1k | 4.3k | 5.3k | 7.9k | 8.0k | 8.5k |
| Other Liabilities | 4.4k | 2.6k | 3.6k | 3.9k | 4.5k | 4.6k | 4.9k | 4.2k |
| Total Liabilities | 11.3k | 11.4k | 13.3k | 14.4k | 16.7k | 20.6k | 21.9k | 22.2k |
| AssetsFixed Assets | 7.4k | 6.8k | 8.3k | 8.5k | 9.7k | 11.0k | 11.3k | 12.3k |
| CWIP | 236 | 234 | 46 | 610 | 873 | 921 | 1.0k | 992 |
| Investments | 434 | 1.3k | 816 | 574 | 986 | 2.5k | 3.0k | 2.2k |
| Other Assets | 3.2k | 3.0k | 4.1k | 4.7k | 5.2k | 6.2k | 6.7k | 6.7k |
| Total Assets | 11.3k | 11.4k | 13.3k | 14.4k | 16.7k | 20.6k | 21.9k | 22.2k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 905 | 1.3k | 1.3k | 1.7k | 1.4k | 1.9k | 2.1k | 2.9k |
| Cash from Investing | -711 | -289 | -880 | -747 | -857 | -1.5k | -3.4k | -2.1k |
| Cash from Financing | -215 | -910 | -340 | -792 | -633 | -311 | 1.3k | -478 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 233 | 782 | 984 | 1.0k | 252 | 785 | 439 | 925 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (80.1×) and current (62.9×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 33.3% growth and a 63× exit, ₹8490 only delivers your return if you pay ₹17,071. The price is currently baking in 18% growth.
EPS grows 33.3%/yr for 5 years, then fades to 6% over 2, exits at 63×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 33.3% | 179.99 |
| FY28 | 33.3% | 239.93 |
| FY29 | 33.3% | 319.83 |
| FY30 | 33.3% | 426.33 |
| FY31 | 33.3% | 568.30 |
| FY32 | 19.6% ·fade | 679.98 |
| FY33 | 6.0% ·fade | 720.77 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.